Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
NYSE COMPOSITE INDX
Gold
Crude Oil
(NQ:
)
N/A
UNCHANGED
Last Price
/ Updated:
/
Add to My Watchlist
View:
Quote
Overview
Detailed Quote
Charting
Options
Historical Prices
News
All News
Press Releases
Related Stories
Blogs
Podcasts
Price and Volume
Detailed Quote
Intraday
1 Week
1 Month
3 Month
1 Year
Compare to:
None
S&P 500
Nasdaq
NYSE
AMEX
Russell 2000
Basic Materials
Conglomerates
Consumer Goods
Financial
Healthcare
Industrial Goods
Services
Technology
Utilities
Volume
0
Open
-
Bid (Size)
N/A (0)
Ask (Size)
N/A (0)
Prev. Close
-
Today's Range
N/A - N/A
52wk Range
N/A - N/A
Shares Outstanding
N/A
Dividend Yield
N/A
Top News
More News
Repros Therapeutics (RPRX) Reverse Split Effective Today
October 15, 2010
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=6033686 for the full story.
Read More
from
StreetInsider.com News Articles
Repros® Announces Reverse Stock Split Effective on Nasdaq October 15, 2010
October 14, 2010
from
Business Wire News Releases
More News
Read More
Repros® Announces Reverse Stock Split Effective on Nasdaq October 15, 2010
October 14, 2010
from
Business Wire News Releases
Repros Therapeutics and Adventrx Pharmaceuticals Presenting at the 2010 Sunshine on Wall Street Healthcare Dinner Conference
October 13, 2010
from
GlobeNewswire News Releases
SmarTrend Detects Continued Selling Pressure in Shares of Repros Therapeutics (RPRX)
October 12, 2010
from
Comtex SmarTrend® News Briefs
On the Run, Penny Stock Repros Therapeutics Moves 4.5% Lower (RPRX)
October 08, 2010
from
Comtex SmarTrend® News Briefs
SmarTrend Detects Continued Selling Pressure in Shares of Repros Therapeutics (RPRX)
October 04, 2010
from
Comtex SmarTrend® News Briefs
RPRX, GENZ, VVUS, CELG are Biotech Stocks Alert from Profitpennystocks.com
October 01, 2010
from
EmailWire.Com Press Releases
UPDATE 1-Repros to meet FDA to discuss testosterone drug trial
September 30, 2010
category
companyNews
from
Reuters: Company News
FDA Grants Type B Meeting to Be Held November 8, 2010 to Discuss Phase III Protocols for Androxal®
September 30, 2010
from
Business Wire News Releases
Stock Market XML and JSON Data API
provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays.
Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
Press Release Service
provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates
Bots go here